Edward Tintoff
Analyst, Piper Sandler
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q2 2023 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q2 2023 earnings conference call, held 2023-08-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Ian Frazier
Interim Chief Medical Officer
Matt Haged
Analyst, OPCO
Greg Tarangio
Principal Accounting Officer
Joseph Schwartz
Analyst, Learing Partners
Judah Frommer
Analyst, Credit Suisse
Alex Sapir
CEO and President
Unknown Participant
Investor (Unidentified)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.089 -- 00:00:05.054 Good morning and welcome to Fulcrum Therapeutics second quarter 2023 00:00:05.054 -- 00:00:09.118 financial results and business update conference call. 00:00:09.118 -- 00:00:12.661 Currently all participants are in a listen-only mode. 00:00:12.661 -- 00:00:18.466 This call is being webcast live on the investor section of Fulcrum's website at 00:00:18.466 -- 00:00:20.466 www.FulcrumTX.com 00:00:22.771 -- 00:00:27.976 and is being recorded. Please be reminded that remarks made during this call 00:00:27.976 -- 00:00:33.317 may contain forward-looking statements within the meaning of the Private Securities 00:00:33.317 -- 00:00:36.887 Litigation Reform Act of 1995. 00:00:37.157 -- 00:00:42.638 These may include statements about the company's future expectations and plans, 00:00:42.638 -- 00:00:46.619 including the clinical hold on FTX-6058 00:00:47.679 -- 00:00:52.008 clinical development timelines and financial projections. 00:00:52.008 -- 00:00:57.432 While these forward-looking statements represent Fulcrum's view as of today, this 00:00:57.432 -- 00:01:02.755 should not be relied upon as representing the company's views in the future. 00:01:02.755 -- 00:01:08.459 Fulcrum may update these statements in the future, but is not taking on an obligation 00:01:08.459 -- 00:01:13.583 to do so. Please refer to Fulcrum's most recent filings with the 00:01:13.583 -- 00:01:18.586 Securities and Exchange Commission for a discussion of certain risks 00:01:18.586 -- 00:01:23.311 and uncertainties associated with the company's business. 00:01:23.311 -- 00:01:28.753 Leading the call today will be Alex Sapir, CEO and President of Fulcrum. 00:01:28.753 -- 00:01:34.216 Joining Alex on the call today are Dr. Ian Frazier, Interim Chief Medical 00:01:34....